Using next-generation sequencing (NGS) methods to analyze cell-free DNA in the blood of patients with myelodysplastic syndrome (MDS) yields more accurate results than the current standard approach of Sanger sequencing.

View post:
Next-generation sequencing to evaluate cell-free DNA yields more accurate results in diagnosis of MDS